Form 4: Life360 Director Sells Shares Under Pre-Arranged Trading Plan

Life360, Inc. Director John Philip Coghlan sold 3,125 shares of common stock for approximately $206,031.25 under a Rule 10b5-1 trading plan, while also undertaking several internal share transfers between trusts.

Summary

• Director John Philip Coghlan sold 3,125 shares of Life360, Inc. common stock on July 1, 2025.
• The shares were sold at a weighted average price of $65.93 per share, with prices ranging from $65.64 to $66.49.
• The total value of the shares sold was approximately $206,031.25.
• The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 6, 2024.
• Following the reported transactions, John Philip Coghlan beneficially owns 15,625 shares indirectly through the John Coghlan Living Trust, 3,344 directly held restricted stock units, and 77,604 shares indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
• Several internal transfers of shares between trusts were also reported, including 1,742 direct shares to the John Coghlan Living Trust, 64,834 shares from The John Philip Coghlan 2024 Grantor Retained Annuity Trust to the John Coghlan Living Trust, and 77,604 shares from the John Coghlan Living Trust to The John Philip Coghlan 2025 Grantor Retained Annuity Trust. These transfers were exempt from Section 16 reporting as acquisitions/dispositions.

Sentiment

Score: 5

Explanation: Neutral. The document reports a routine insider share sale under a pre-arranged plan and internal transfers, which is a standard disclosure and does not inherently indicate positive or negative sentiment about the company's prospects.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction not based on recent material nonpublic information.

Negatives

• A director selling shares could be perceived negatively by some investors, although the sale was pre-planned.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024.
• The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
• The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context or competitive analysis. Insider sales, even pre-planned, are common in the tech industry for diversification or liquidity purposes.

Comparison to Industry Standards

• This document is a standard insider trading report (Form 4) and does not contain information that allows for a direct comparison of company performance or financial results to industry benchmarks or specific comparable companies/projects. The reported share price of $65.93 is specific to Life360, Inc. at the time of the transaction.

Stakeholder Impact

• Shareholders: The sale by a director could be interpreted differently by shareholders, though the 10b5-1 plan mitigates concerns about opportunistic selling. The internal transfers do not directly impact other shareholders.

Next Steps

• The Reporting Person undertakes to provide full details regarding the number of shares sold at each separate price within the range upon request.

Key Dates

Keywords

Life360, LIF, Form 4, Insider Trading, Share Sale, Director, John Philip Coghlan, Rule 10b5-1, Beneficial Ownership, SEC Filing